findmyKOL
Clinical trialNCT01854567CompletedPhase 3Interventional

P3 Study of Umbilical Cord Blood Cells Expanded With MPCs for Transplantation in Patients With Hematologic Malignancies

SponsorMesoblast, Ltd.Enrollment49Acute Lymphoblastic LeukemiaAcute Myelogenous LeukemiaHodgkin's DiseaseNon-Hodgkin's Lymphoma
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The study investigates the time to engraftment of a mesenchymal expanded cord blood unit in patients with hematologic malignancies undergoing transplantation with myeloablative conditioning.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • University of Miami Health System Sylvester Comprehensive Cancer Center

    Miami, Florida, United States

  • Moffitt Cancer Center

    Tampa, Florida, United States

  • Beth Israel Deaconess Medical Center

    Boston, Massachusetts, United States

  • Memorial Sloan Kettering Cancer Center

    New York, New York, United States

  • Weill Cornell-New York Presbyterian Hospital

    New York, New York, United States

  • Westchester Medical Center

    Valhalla, New York, United States

  • Case Western

    Cleveland, Ohio, United States

  • Md Anderson Cancer Center

    Houston, Texas, United States

  • Texas Transplant Center at Methodist Healthcare System

    San Antonio, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Infusion of one MPC expanded cord unit and one unexpanded cord unitInfusion of two unexpanded cord blood units
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Aug 2013
Primary completion
23 Sept 2016
Completion
5 May 2017
Last update posted
26 Jun 2020
Registered enrollment
49
Registry id
NCT01854567
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.